OTCMKTS:VBIO - Vitality Biopharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.1950 +0.04 (+1.86 %)
(As of 09/21/2018 03:27 PM ET)
Previous Close$2.15
Today's Range$2.07 - $2.22
52-Week Range$1.05 - $2.37
Volume330,611 shs
Average Volume240,095 shs
Market Capitalization$45.37 million
P/E RatioN/A
Dividend YieldN/A
Beta1.22
Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States. The company's products in pipeline include VBX-100, an oral cannabinoid formulation for inflammatory bowel disease, C.difficile-associated diarrhea and colitis, and narcotic bowel syndrome; and VBX-210, a cannabinoid formulation, which is in preclinical studies for the treatment of gastrointestinal conditions. It develops additional cannabinoid product formulations for refractory pain and autism spectrum disorder. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. The company was founded in 2007 and is based in Los Angeles, California.

Receive VBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for VBIO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:VBIO
CUSIPN/A
Phone530-231-7800

Debt

Debt-to-Equity RatioN/A
Current Ratio0.35
Quick Ratio0.35

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$100,000.00
Price / Sales495.41
Cash FlowN/A
Price / CashN/A
Book Value$0.01 per share
Price / Book219.50

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-4,300,000.00
Net Margins-5,036.05%
Return on Equity-1,420.00%
Return on Assets-566.14%

Miscellaneous

Employees7
Outstanding Shares22,570,000
Market Cap$45.37 million

Vitality Biopharma (OTCMKTS:VBIO) Frequently Asked Questions

What is Vitality Biopharma's stock symbol?

Vitality Biopharma trades on the OTCMKTS under the ticker symbol "VBIO."

How were Vitality Biopharma's earnings last quarter?

Vitality Biopharma Inc (OTCMKTS:VBIO) announced its earnings results on Thursday, June, 28th. The company reported ($0.04) earnings per share (EPS) for the quarter. The business earned $0.03 million during the quarter. Vitality Biopharma had a negative net margin of 5,036.05% and a negative return on equity of 1,420.00%. View Vitality Biopharma's Earnings History.

When is Vitality Biopharma's next earnings date?

Vitality Biopharma is scheduled to release their next quarterly earnings announcement on Thursday, September, 27th 2018. View Earnings Estimates for Vitality Biopharma.

Who are some of Vitality Biopharma's key competitors?

Who are Vitality Biopharma's key executives?

Vitality Biopharma's management team includes the folowing people:
  • Mr. Robert T. Brooke, CEO, Sec., Treasurer & Director (Age 38)
  • Dr. Brandon J. Zipp Ph.D., Scientific Co-Founder and Director of R&D
  • Dr. J. Jeremiah Mann, VP of Operations & Sr. Agronomist
  • Mr. Richard McKilligan, Controller (Age 54)
  • Dr. Dong Yuejin, Partner

Has Vitality Biopharma been receiving favorable news coverage?

Headlines about VBIO stock have trended somewhat positive on Friday, according to Accern Sentiment. Accern identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Vitality Biopharma earned a news and rumor sentiment score of 0.18 on Accern's scale. They also assigned news coverage about the company an impact score of 46.57 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future. View Recent Headlines for Vitality Biopharma.

How do I buy shares of Vitality Biopharma?

Shares of VBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Vitality Biopharma's stock price today?

One share of VBIO stock can currently be purchased for approximately $2.1950.

How big of a company is Vitality Biopharma?

Vitality Biopharma has a market capitalization of $45.37 million and generates $100,000.00 in revenue each year. Vitality Biopharma employs 7 workers across the globe.

How can I contact Vitality Biopharma?

Vitality Biopharma's mailing address is 1901 AVENUE OF THE STARS 2ND FLOOR, LOS ANGELES CA, 90067. The company can be reached via phone at 530-231-7800 or via email at [email protected]


MarketBeat Community Rating for Vitality Biopharma (OTCMKTS VBIO)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  108 (Vote Outperform)
Underperform Votes:  105 (Vote Underperform)
Total Votes:  213
MarketBeat's community ratings are surveys of what our community members think about Vitality Biopharma and other stocks. Vote "Outperform" if you believe VBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/21/2018 by MarketBeat.com Staff

Featured Article: How a Put Option Works

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel